Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  nausea and vomiting
Trial Type:  Supportive care
Results 1-13 of 13 for your search:
Start Over
Acupressure in Controlling Nausea in Young Patients with Central Nervous System or Solid Tumors Receiving Nausea-Inducing Chemotherapy
Phase: Phase III
Type: Supportive care
Age: 4 to 18
Trial IDs: SCUSF 1202, NCI-2011-02668, ACCL1032, CDR0000699766, COG-ACCL1032, NCT01346267
Dexmedetomidine Hydrochloride in Reducing Pain in Patients Undergoing Thoracic Surgery
Phase: Phase III
Type: Supportive care
Age: 21 and over
Trial IDs: 13-163, NCI-2013-02150, NCT01973452
Ropivacaine Hydrochloride via Paravertebral Blocks before Surgery in Decreasing Pain in Patients with Breast Cancer
Phase: Phase III
Type: Supportive care
Age: 18 to 100
Trial IDs: J1284, NCI-2014-01365, 311945, NA_00075957, NCT02161705
The Effects of Ginseng on Cancer-Related Fatigue
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0854, NCI-2011-01127, NCT01375114
Ondansetron with or without Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Gliomas
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00031206, NCI-2013-00520, NCT01450826
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, 1211010041, 1211010041R001, HOG QL12-153, NCT01736917
Palonosetron Hydrochloride in Treating Nausea and Vomiting in Terminally Ill Patients
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UMCC 2008.048, NCI-2011-03614, NCT00982995
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: GOG-0272, NCI-2011-02660, CDR0000692516, NCT01275664
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients with Breast Cancer Undergoing Chemotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 1B-11-5, NCI-2012-01170, HS-11-00443, NCT01649258
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients with Newly Diagnosed Acute Leukemia Undergoing Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: Not specified
Trial IDs: OSU-14182, NCI-2015-00549, 2014C0156, NCT02445378
Omalizumab in Reducing Refractory Type I Hypersensitivity Reactions in Patients with Cancer Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 13-485, NCI-2014-02030, NCT02118987
Start Over